BE773113A - Composition pharmaceutique a liberation progressive de la substance active - Google Patents

Composition pharmaceutique a liberation progressive de la substance active

Info

Publication number
BE773113A
BE773113A BE773113A BE773113A BE773113A BE 773113 A BE773113 A BE 773113A BE 773113 A BE773113 A BE 773113A BE 773113 A BE773113 A BE 773113A BE 773113 A BE773113 A BE 773113A
Authority
BE
Belgium
Prior art keywords
pharmaceutical composition
active substance
progressive release
progressive
release
Prior art date
Application number
BE773113A
Other languages
English (en)
French (fr)
Original Assignee
Controlled Medications
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB4608670A external-priority patent/GB1359643A/en
Application filed by Controlled Medications filed Critical Controlled Medications
Publication of BE773113A publication Critical patent/BE773113A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
BE773113A 1970-09-28 1971-09-27 Composition pharmaceutique a liberation progressive de la substance active BE773113A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4608670A GB1359643A (en) 1970-09-28 1970-09-28 Controlled release medicament
US8254870A 1970-10-19 1970-10-19

Publications (1)

Publication Number Publication Date
BE773113A true BE773113A (fr) 1972-01-17

Family

ID=26265730

Family Applications (1)

Application Number Title Priority Date Filing Date
BE773113A BE773113A (fr) 1970-09-28 1971-09-27 Composition pharmaceutique a liberation progressive de la substance active

Country Status (5)

Country Link
BE (1) BE773113A (da)
CA (1) CA952431A (da)
DE (1) DE2148391A1 (da)
FR (1) FR2108032A1 (da)
NL (1) NL7113307A (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
JPS55129219A (en) * 1979-03-29 1980-10-06 Asahi Chem Ind Co Ltd Slow-releasing preparation
DE3126703A1 (de) * 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach Bromhexin-retardform und verfahren zu ihrer herstellung
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
US20030232890A1 (en) 2000-11-01 2003-12-18 Sention, Inc. Methods for treating an impairment in memory consolidation
TWI291871B (en) * 2000-11-01 2008-01-01 Cognition Pharmaceuticals Llc Pharmaceutical compositions and use of amphetamine compounds for improving memory and learning

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB793808A (en) * 1954-07-22 1958-04-23 Frank Mario Bardani Sustained action pill
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets

Also Published As

Publication number Publication date
FR2108032A1 (en) 1972-05-12
FR2108032B1 (da) 1975-02-07
CA952431A (en) 1974-08-06
DE2148391A1 (de) 1972-04-06
NL7113307A (da) 1972-03-30

Similar Documents

Publication Publication Date Title
CA936472A (en) Formulation for sustained release of a biological agent
NO142670C (no) Benzylpenicillinester for anvendelse som utgangsmateriale ved fremstilling av en terapeutisk virksom ester av alfa-aminobenzylpenicilliner
CH538281A (fr) Capsule pharmaceutique verrouillée
BE768269A (fr) Composition pharmaceutique
IE34966B1 (en) The pharmaceutical use of certain substituted biguanides
NO138883C (no) Fremgangsmaate for fremstilling av oksiranforbindelser
CH543281A (de) Einrichtung für die Verabreichung von Empfängnis-verhütungsmitteln
SE399701B (sv) Forfarande for framstellning av hydroxyalkyldiamin
BE782981A (fr) Compositions pharmaceutiques
BE773113A (fr) Composition pharmaceutique a liberation progressive de la substance active
SE396072B (sv) Anvendning av cis-dihydrometyljasmonat som luktemne
BE775640A (fr) Composition pharmaceutique
IT940426B (it) Supporto sferico
SE394436B (sv) Forfarande for framstellning av 7-halogen-linkomyciner
BE782444A (fr) Compositions pharmaceutiques
SE385011B (sv) Forfarande for framstellning av alfa-linkosaminider
BE777158A (fr) Compositions pharmaceutiques encapsulees
AR199762A1 (es) Procedimiento para la preparacion de 5-fluoro-pirimidinas
BE764768A (fr) Compositions pharmaceutiques
BE757586A (fr) Forme pharmaceutique a liberation programmee de la substance active
BE770399A (fr) Composition pharmaceutique
AR206692A1 (es) Agente dispensador de liberacion sostenida de substancias activas
AT332640B (de) Trennmittelgemisch
BE776769A (fr) Composition pharmaceutique
SE411759B (sv) Forfarande for framstellning av erytromycyliminforeningar